Home The History of Synthetic Biology Designing Synthetic Biotics Pipeline Our People Leadership Board of Directors Founders and Advisors Investors + Media Company Overview News News Releases In the News Events & Presentations Events Presentations Publications Stock Information Stock Quote & Chart Analyst Coverage Corporate Governance Governance Highlights Management Team Board of Directors Committee Composition Board Diversity Matrix Financials Quarterly Results Investor Resources FAQs Contact IR Email Alerts RSS Feeds Synlogic Announces First Industry Collaboration to Develop a New Class of Medicines Designed to Power the Microbiome Read more about Synlogic Announces First Industry Collaboration to Develop a New Class of Medicines Designed to Power the Microbiome Synlogic Secures $40 Million in Series B Financing Read more about Synlogic Secures $40 Million in Series B Financing Synlogic Appoints an Industry Leader Nick Leschly to its Board of Directors Read more about Synlogic Appoints an Industry Leader Nick Leschly to its Board of Directors Synlogic Proprietary Synthetic Biotic Receives FDA Orphan Drug Designation Read more about Synlogic Proprietary Synthetic Biotic Receives FDA Orphan Drug Designation Synlogic Expands Leadership Team to Support Rapid Advancement of the First Synthetic Biotic Towards the Clinic Read more about Synlogic Expands Leadership Team to Support Rapid Advancement of the First Synthetic Biotic Towards the Clinic Synlogic Secures Patent on Proprietary Synthetic Probiotic Bacteria for the Treatment of Hyperammonemia Read more about Synlogic Secures Patent on Proprietary Synthetic Probiotic Bacteria for the Treatment of Hyperammonemia Synlogic Appoints COO and Head of Corporate Development Read more about Synlogic Appoints COO and Head of Corporate Development Synlogic to Present at 2017 American College of Medical Genetics and Genomics Annual Meeting Read more about Synlogic to Present at 2017 American College of Medical Genetics and Genomics Annual Meeting Synlogic and Mirna Therapeutics Agree to Merger Read more about Synlogic and Mirna Therapeutics Agree to Merger Synlogic and Mirna Investor Conference Call Information Read more about Synlogic and Mirna Investor Conference Call Information Pagination First page « First Previous page ‹ Previous … Page 16 Page 17 Page 18 Page 19 Page 20 Page 21 Page 22 Current page 23 Page 24 Next page Next › Last page Last » Subscribe to Investor Resources Contact IR Investor FAQs RSS Feeds Investor Email Alerts Email
Synlogic Announces First Industry Collaboration to Develop a New Class of Medicines Designed to Power the Microbiome Read more about Synlogic Announces First Industry Collaboration to Develop a New Class of Medicines Designed to Power the Microbiome
Synlogic Secures $40 Million in Series B Financing Read more about Synlogic Secures $40 Million in Series B Financing
Synlogic Appoints an Industry Leader Nick Leschly to its Board of Directors Read more about Synlogic Appoints an Industry Leader Nick Leschly to its Board of Directors
Synlogic Proprietary Synthetic Biotic Receives FDA Orphan Drug Designation Read more about Synlogic Proprietary Synthetic Biotic Receives FDA Orphan Drug Designation
Synlogic Expands Leadership Team to Support Rapid Advancement of the First Synthetic Biotic Towards the Clinic Read more about Synlogic Expands Leadership Team to Support Rapid Advancement of the First Synthetic Biotic Towards the Clinic
Synlogic Secures Patent on Proprietary Synthetic Probiotic Bacteria for the Treatment of Hyperammonemia Read more about Synlogic Secures Patent on Proprietary Synthetic Probiotic Bacteria for the Treatment of Hyperammonemia
Synlogic Appoints COO and Head of Corporate Development Read more about Synlogic Appoints COO and Head of Corporate Development
Synlogic to Present at 2017 American College of Medical Genetics and Genomics Annual Meeting Read more about Synlogic to Present at 2017 American College of Medical Genetics and Genomics Annual Meeting
Synlogic and Mirna Therapeutics Agree to Merger Read more about Synlogic and Mirna Therapeutics Agree to Merger
Synlogic and Mirna Investor Conference Call Information Read more about Synlogic and Mirna Investor Conference Call Information